Many factors contribute to mortality in lung cancer, including the presence of concomitant
cardiovascular disease. In the treatment of early stage of lung cancer, the presence of …

Background: Pulmonary embolism (PE) is accompanied by high morbidity and mortality. The
search for simple and easily assessable risk stratification scores with favourable …

Purpose: Computed tomography pulmonary angiography (CT-PA) is frequently used in the
diagnostic workup of pulmonary embolism (PE), even in highly radiosensitive patient …

Background. Percutaneous catheter‐based ultrasound‐assisted thrombolysis (UACDT) is
recommended for patients with intermediate‐high‐risk or high‐risk pulmonary embolism …

Introduction Pulmonary embolism (PE) patients at low risk of early complications may be
considered for early discharge or home treatment. Last decades evidence has been growing …

Pulmonary embolism (PE) is the third most common cause of cardiovascular death and
necessitates prompt, accurate risk assessment at initial diagnosis to guide treatment and …

Haemodynamic instability and right ventricular dysfunction are the key determinants of short-
term prognosis in patients with acute pulmonary embolism (PE). Residual thrombi and …

Pulmonary Embolisms (PE) represent a leading cause of cardiovascular death. While
medical imaging, through computed tomographic pulmonary angiography (CTPA) …

Accurate estimation of risk with both imaging and biochemical parameters in intermediate
risk pulmonary embolism (PE) remains challenging. The aim of the study was to evaluate …

Pulmonary embolism (PE) is the third most common acute cardiovascular disease. The risk
of PE increases with age and mortality is high. Patients are stratified into hemodynamically …